Nia Adeniji, MD
RESIDENT
Medicine
School of Medicine

Education & Training

Show all (3) Hide

• MD Medicine Stanford 06/2021
• M Eng Biological Engineering MIT 06/2009
• BS Biological Chemical Engineering MIT 06/2007

Publications (9)

Top publication keywords:
Socioeconomic FactorsLiver NeoplasmsLiver DiseasesProto-Oncogene Proteins c-mycBiomarkers, TumorTwist-Related Protein 1Acute Lung InjuryLiver TransplantationCathepsin BLiver Diseases, AlcoholicMinority GroupsLiver CirrhosisEarly Detection of CancerCarcinoma, HepatocellularChemoembolization, Therapeutic

• Current and Emerging Tools for Hepatocellular Carcinoma Surveillance.
  Hepatology communications 2021 Adeniji N, Dhanasekaran R
• Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma Factors.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2021 Adeniji N, Arjunan V, Prabhakar V, Mannalithara A, Ghaziani T, Ahmed A, Kwo P, Nguyen M, Melcher ML, Busuttil RW, Florman SS, Haydel B, Ruiz RM, Klintmalm GB, Lee DD, Burcin Taner C, Hoteit MA, Verna …
• Student engagement in the online classroom: comparing preclinical medical student question-asking behaviors in a videoconference versus in-person learning environment.
  FASEB bioAdvances 2020 Caton JB, Chung S, Adeniji N, Hom J, Brar K, Gallant A, Bryant M, Hain A, Basaviah P, Hosamani P
• Liver Injury in Liver Transplant Recipients With Coronavirus Disease 2019 (COVID-19): U.S. Multicenter Experience.
  Hepatology (Baltimore, Md.) 2020 Rabiee A, Sadowski B, Adeniji N, Perumalswami PV, Nguyen V, Moghe A, Latt NL, Kumar S, Aloman C, Catana AM, Bloom PP, Chavin KD, Carr RM, Dunn W, Chen VL, Aby ES, Debes JD, Dhanasekaran R, COLD …
• Impact of Bridging Locoregional Therapies for Hepatocellular Carcinoma on Post-transplant Clinical Outcome.
  Clinical transplantation 2020 Adeniji N, Arjunan V, Prabhakar V, Tulu Z, Kambham N, Ahmed A, Kwo P, Dhanasekaran R

Show all (4 more) Hide

• Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Minorities With Chronic Liver Diseases.
  Gastroenterology 2020 Adeniji N, Carr RM, Aby ES, Catana AM, Wegermann K, Dhanasekaran R
• Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2020 Kim D, Adeniji N, Latt N, Kumar S, Bloom PP, Aby ES, Perumalswami P, Roytman M, Li M, Vogel AS, Catana AM, Wegermann K, Carr RM, Aloman C, Chen VL, Rabiee A, Sadowski B, Nguyen V, Dunn W, Chavin KD, …
• MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity.
  eLife 2020 Dhanasekaran R, Baylot V, Kim M, Kuruvilla S, Bellovin DI, Adeniji N, Rajan Kd A, Lai I, Gabay M, Tong L, Krishnan M, Park J, Hu T, Barbhuiya MA, Gentles AJ, Kannan K, Tran PT, Felsher DW
• Cathepsin B Cleavage of vcMMAE-Based Antibody-Drug Conjugate Is Not Drug Location or Monoclonal Antibody Carrier Specific.
  Bioconjugate chemistry 2016 Gikanga B, Adeniji NS, Patapoff TW, Chih HW, Yi L